Notably, 77% of the affected polypeptides (FDR < 0.05) in sporadic patients are also downregulated in LRRK2-G2019S PD, indicating that the underlying mechanism is at least partly shared in both types of PD (Fig. 5a). Here, LRRK2 is linked to Parkinson disease.